Investment Details
Investor Type
Venture Capital
Asset Class Focus
Venture Capital
Stage Focus
Pre-Seed, Seed, Early Stage, Series A, Series B, Growth, Late Stage, Pre-IPO
Geographical Focus
United Kingdom
Industries Focus
- Technology
- Healthcare
- Consumer Goods
- EdTech
- FinTech
- Artificial Intelligence
- Life Sciences
- AgriTech
- Sustainability
- Medtech
- Quantum Computing
- Biotechnology
- Cleantech
- Engineering
- Materials Science
Investment Size:
20,000 to 1,000,000 USD
Investor Details Founded: 1995
Cambridge Enterprise Ventures is the investment arm of the University of Cambridge, dedicated to supporting the commercialization of university research and innovation. By investing ring-fenced University capital, they accelerate and share in the unique challenges and journeys of university talent startups and spinouts. Their investment options include Pathfinder (up to £20K), Pre-seed funding (up to £150K), Seed investment (up to £500K), and Follow-on Investment (up to £1M), always working alongside other investors to provide continued support as a company grows. They also collaborate with Parkwalk Advisors to deploy the University of Cambridge Enterprise Fund, which can double the financial support available for EIS.
Their portfolio includes 174 companies across a wide range of sectors, with a total value of £104 million. In 2023–24, they invested £6.5 million in 41 transactions and formed 25 new companies. Since 1995, they have managed investments made by the University Venture Fund into new companies, using ring-fenced University capital, with all returns supporting future Cambridge innovations. The fund holds several key investments, including companies in their sustainability portfolio.
Cambridge Enterprise Ventures is committed to supporting future generations of early-stage companies, providing not only financial investment but also guidance on preparing for investor discussions, introductions to experienced experts and mentors, and assistance with ongoing business management, including links to later-stage investors. They are Cambridge, investing in Cambridge, supporting future generations of early-stage companies.
Requirements
- University of Cambridge affiliation (students, academics, alumni, staff)
Contact
[Official Website Hidden]
[LinkedIn Profile Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Riverlane
- T-Therapeutics
- Cambridge Quantum Computing
- Cambridge Medical Robotics
- Cambridge Epigenetix
- Cambridge Immunotherapy
- Cambridge Design Partnership
- Cambridge NanoTech
- Cambridge Graphene Centre
- Cambridge Bio-Augmentation Systems
- Cambridge Advanced Imaging Centre
Claim this Investor
Are you an official representative of Cambridge Enterprise Ventures?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim